Revenue segments as reported by the company.

Net revenue, before excise taxes

Excise taxes

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

Research and development

General and administrative

Restructuring costs

Share-based payments

Depreciation and amortization

Impairment loss on goodwill and indefinite-lived intangible assets

Impairment loss on long-lived assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cronos Group

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.

Greenlane Holdings

Aurora Cannabis

Canopy Growth

Tilray Brands

As the cannabis industry continues its growth in 2024, a confluence of regulatory, demographic, and market trends is shaping the sector. This has presented a fertile ground for savvy investors. Here's a deeper look into the evolving landscape of cannabis investments. This year could mark a significant turning point with the potential rescheduling of cannabis at the federal level. If cannabis can one day be federally legal it would be the biggest win for the industry.

This Is How Marijuana Stocks Will Be Impacted By Reform In 2024

Archer Aviation

Bitfarms Ltd

Lithium Americas Corp

Ring Energy

Solid Power

My view is that expansionary monetary policy in the second half of 2024 is likely to be a major catalyst for a broad-based market rally. It's therefore a good time to accumulate high-quality growth stocks.

7 Massively Undervalued Penny Stocks to Buy for 7-Bagger Returns

Curaleaf Holdings, Inc.

Jazz Pharmaceuticals

Leafly Holdings

Among the emerging industries that have captured the attention of investors is the cannabis sector. The cannabis industry has experienced remarkable growth, giving rise to a new breed of top cannabis stocks to buy for investments in May.

7 Cannabis Stocks to Buy for a Smoking-Hot 2024

Shares of Cronos Group Inc. CRON CA:CRON climbed 3.1% in premarket trading, after the cannabis company reported revenue that rose to a record and beat expectations, citing strength in flower sales in Canada and Israel. The company reported a net loss of $24.7 million, or 1 cent a share, after a loss of $16.8 million, or 5 cents a share, in the same period a year ago, to match the FactSet consensus for per-share losses of 1 cent.

Cronos' stock rallies after revenue rises to a record, amid strength in cannabis flower sales

Industry-leading balance sheet with $855 million in cash and cash equivalents Net revenue in Q1 2024 increased by 30% year-over-year to $25.3 million Spinach ® was top-3 in retail sales in Canada in the flower, edible, and vape categories in Q1 2024 Launched PEACE NATURALS ® brand in the United Kingdom in May 2024 TORONTO, May 09, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), today announces its 2024 first quarter business results. “Cronos achieved its highest quarterly net revenue from continuing operations on record at $25.3 million, up 30% year-over-year.

Cronos Group Reports 2024 First Quarter Results

Joby Aviation

Riot Blockchain

The rules of investing have significantly changed over the years. That particularly holds true for investors looking for short-term gains.

The 3 Best Meme Stocks to Buy in May 2024

TORONTO, May 07, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announced today that it is expanding its medical brand, PEACE NATURALS, into the United Kingdom market with its first shipment of cannabis flower to GROW® Pharma, a leading distributor of prescribed medicinal cannabis products in the UK.

Cronos Enters United Kingdom Cannabis Market

AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure Cannabis ETF 

The proposed rescheduling of cannabis is the biggest step forward for the industry in decades.

Cannabis Continues Powering To Big Gains With Historic DEA Rescheduling

High Tide

Village Farms International

As May 2024 begins, Canadian cannabis companies are catching the eye of savvy investors. Among these, Canopy Growth Corporation and Aurora Cannabis stand out for their expansive market reach and innovation. These companies have been pioneers in the cannabis industry, expanding their operations globally. They are well-positioned to capitalize on emerging markets. This is due to their early entry and continuous investment in research and development.

May 2024 Watchlist: Leading Canadian Cannabis Stocks Poised for Growth

The DEA recommended loosening regulations on marijuana yesterday. As a Schedule III drug, marijuana would still be regulated and some costs would rise for cannabis companies -- but others would fall.

Why Canopy Growth, Tilray, and Cronos Group Stocks Just Cratered

Canopy Growth Corp. and Tilray Brands Inc. stocks made more modest moves on Wednesday after a huge rally in the previous session on plans by the Biden administration to reclassify pot as less dangerous under federal law.

Cannabis stocks settle down after rally on plans to reclassify pot as less dangerous

Warren Buffett is a well-known proponent of value investing. The legendary investor waits for the right valuation before making a big plunge.

Stock Market Crash Alert: 3 Must-Buy Cannabis Stocks When Prices Plunge

WASHINGTON — The U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug, the Associated Press has learned, a historic shift to generations of American drug policy that could have wide ripple effects across the country.

U.S. poised to ease restrictions on marijuana in historic shift, though it'll remain controlled substance

The US is planning to reclassify cannabis as a less dangerous drug in an historic shift that could have a significant impact across the country.

US plans to reclassify cannabis as less dangerous drug

SNDL Inc.

The DEA officially agreed to recommend rescheduling cannabis from a Class I to a Class III drug. While it doesn't legalize cannabis, the measure has the potential to be hugely impactful to U.S. multi-state operators.

Why Cannabis Companies Tilray, Canopy Growth, Cronos, and SNDL Got Really High on Tuesday

Green Thumb Industries Inc.

Trulieve Cannabis Corp.

Shares of cannabis companies surged on Tuesday afternoon after the U.S. Department of Justice (DoJ) moved to reclassify marijuana as a less dangerous drug.

Pot stocks jump as U.S. DOJ moves to reclassify cannabis as a less dangerous drug

Cannabis stocks surged on Tuesday afternoon following multiple media reports that the US Drug Enforcement Administration will approve the reclassification of marijuana as a lower-risk drug. The news was first reported by the Associated Press, which cited five people familiar with the matter.

Cannabis stocks surge on reports DEA will approve rescheduling of marijuana as lower-risk drug

A January Pew Research survey indicates that 88% of U.S. adults support the legalization of cannabis for medicinal use. Further, 57% adults opine that the legalization should be for recreational use as well.

3 Hot Cannabis Stocks With Multibagger Return Potential Before the Presidential Election

The U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug, the Associated Press reported on Tuesday, citing five people familiar with the matter.

US drug enforcers to ease restrictions on cannabis, AP reports

Amplify Alternative Harvest ETF

Cannabis stocks were up sharply on Tuesday on a report by the Associated Press that the U.S. Drug Enforcement Administration is poised to propose the lowering of cannabis to a Schedule III controlled substance. For more than 50 years, cannabis has been a Schedule I substance under federal law, in the same bucket as heroin and fentanyl.

Cannabis stocks rally as AP reports imminent rescheduling proposal by DEA

IAMGOLD

For penny stocks whose time has come, 100% or 200% returns come in the blink of an eye. This is irrespective of broad market conditions.

3 Hot Penny Stocks That Can Rocket 100% in the Blink of an Eye

TORONTO, April 26, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2024 Annual Meeting of Shareholders on Thursday, June 20, 2024, at 11:00 a.m. ET.

Cronos Group Inc. to Hold Virtual 2024 Annual Meeting of Shareholders

It's been a wild journey for cannabis stocks in the last eight years. There have been phases of euphoria that have quickly fizzled out.

3 Cannabis Stocks That Could Be Multibaggers in the Making: April Edition

TORONTO, April 25, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2024 first quarter earnings conference call on Thursday, May 9, 2024 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks.

Cronos Group Inc. to Hold 2024 First Quarter Earnings Conference Call on May 9, 2024

Innovative Industrial Properties

Investor sentiment behind cannabis stocks has swung wildly over the past several years. It always seems to be a case of weighing the opportunity for further legalization against the fundamental realities of the sector.

The Only 3 Cannabis Stocks Sensible Investors Are Buying

News for Cronos Group Stock (CRON)